ResearcherWenzhou Medical UniversityNo recent work listed

Aimin Cai

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5055539617. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2020: 1 paper

Papers 1

Synergism between SLC6A14 blockade and gemcitabine in pancreactic cancer: a 1H-NMR-based metabolomic study in pancreatic cancer cells. Co-author DOI 10.1042/bcj20200275 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yangzom Doma Bhutia · 1 shared paper, 2020 · strength 0.11
- Paper Synergism between SLC6A14 blockade and gemcitabine in pancreactic cancer: a 1H-NMR-based metabolomic study in pancreati… DOI 10.1042/bcj20200275 ↗
Ruijie Chen · 1 shared paper, 2020 · strength 0.11
- Paper Synergism between SLC6A14 blockade and gemcitabine in pancreactic cancer: a 1H-NMR-based metabolomic study in pancreati… DOI 10.1042/bcj20200275 ↗
Longfa Kou · 1 shared paper, 2020 · strength 0.11
- Paper Synergism between SLC6A14 blockade and gemcitabine in pancreactic cancer: a 1H-NMR-based metabolomic study in pancreati… DOI 10.1042/bcj20200275 ↗
Hailun Zheng · 1 shared paper, 2020 · strength 0.11
- Paper Synergism between SLC6A14 blockade and gemcitabine in pancreactic cancer: a 1H-NMR-based metabolomic study in pancreati… DOI 10.1042/bcj20200275 ↗
Vadivel Ganapathy · 1 shared paper, 2020 · strength 0.11
- Paper Synergism between SLC6A14 blockade and gemcitabine in pancreactic cancer: a 1H-NMR-based metabolomic study in pancreati… DOI 10.1042/bcj20200275 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.